Treatment planning in cutaneous T-Cell lymphoma

Dermatologic Therapy

Volumn 16, Issue 4, 2003, Pages 276-282

  Vonderheid, Eric C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cutaneous T cell lymphoma; Mycosis fungoides; Treatment

Indexed keywords

BEXAROTENE; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DENILEUKIN DIFTITOX; GAMMA INTERFERON; METHOTREXATE; PENTOSTATIN; PURINE NUCLEOSIDE DERIVATIVE; RECOMBINANT ALPHA INTERFERON;

CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CUTANEOUS T CELL LYMPHOMA; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; ELECTRON BEAM; HEALTH STATUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MEDICAL DECISION MAKING; MYCOSIS FUNGOIDES; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PUVA; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SEZARY SYNDROME; TREATMENT OUTCOME; TREATMENT PLANNING; ULTRAVIOLET B RADIATION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; METHODS; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PHOTOCHEMOTHERAPY; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0347990608     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1396-0296.2003.01638.x     Document Type: Review

References (16)

1. Vonderheid EC. Treatment of cutaneous T-cell lymphoma: 2001. Recent Results Cancer Res 2002: 160: 309-320.
2. Kim YH, Hoppe RT. Mycosis fungoides and the Sézary syndrome. Semin Oncol 1999: 26: 276-289.
3. Quaglino P, Zaccagna A, Verrone A, Dardano F, Bernengo MG. Mycosis fungoides in patients under 20 years of age. Report of 7 cases, review of the literature and study of the clinical course. Dermatol 1999: 199: 8-14.
4. Zackheim HS, McClamont TH, Deanovic FW, Odom RB. Mycosis fungoides with onset before 20 years of age. J Am Acad Dermatol 1999: 36: 557-562.
5. Swanbeck G, Roupe G, Sandstrom MH. Indications of a considerable decrease in the death rate in mycosis fungoides by PUVA treatment. Acta Derm Venereol 1994: 74: 465-466.
6. Vonderheid EC, Tan ET, Kantor AF, Shrager L, Micaily B, Van Scott EJ. Long-term efficacy, curative potential and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol 1989: 20: 416-428.
7. van Doorn R, Van Haselen CW, van Voorst Vader PC, et al. Mycosis fungoides: disease evolution and prognosis in 309 Dutch patients. Arch Dermatol 2000: 136: 504-510.
8. Resnik KS, Vonderheid EC. Home ultraviolet phototherapy of early mycosis fungoides: long-term follow-up observations. J Am Acad Dermatol 1993: 29: 73-77.
9. Kim YH, Chow S, Varghese A, Hoppe RT. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 1999: 135: 26-32.
10. Micaily B, Miyamoto C, Kantor G, et al. Radiotherapy for unilesional mycosis fungoides. Int J Rad Oncol Biol Phys 1998: 42: 361-364.
11. Wilson LD, Kacinski BM, Jones GW. Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiation Oncol Biol Phys 1998: 40: 109-115.
12. Vonderheid EC, Diamond LW, Lai SM, Au F, Dellavecchia M. Lymph node histopathologic findings in cutaneous T-cell lymphoma. Am J Clin Pathol 1992: 97: 121-129.
13. Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermtol 2002: 46: 95-106.
14. Muche JM, Lukowsky A, Asadullah K, Gellrich S, Sterry W. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood 1997: 90: 1636-1642.
15. Fraser-Andrews EA, Woolford AJ, Seed PT, Russell-Jones R, Whittaker SJ. Detection of a peripheral blood T-cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 2000: 114: 117-121.
16. Beylot-Barry M, Sibaud V, Thiebaut R et al. Evidence that an identical T cell clone in skin and peripheral blood lymphocytes in an independent prognostic factor in primary cutaneous T cell lymphomas. J Invest Dermatol 2001: 117: 920-926.